Megacities contain at least 10 million people whose wellbeing largely depends on ecosystem services provided by remote natural areas.
![](https://sdgresources.relx.com/sites/default/files/styles/sus_content_listing_image/public/lablinks_header_800x120px.png?itok=tvXgFpPS)
How can innovations in chemistry, energy, and biotechnology jointly be applied in low-resource settings for the benefit of a community?
This LabLinks meeting combines the expertise in the applied biosciences of Trends in Biotechnology, Joule’s interest in both scientific and sustainability developments in energy, and Chem’s focus on basic chemical science with relevance to the United Nations Sustainable Development Goals.
Elsevier,
Journeys of Embodiment at the Intersection of Body and Culture, The Developmental Theory of Embodiment, 2017, Pages 201-256
This chapter advances goals 3 and 5 by examining how the adult women can recapture physical and mental freedom, empowering relationships and membership in equitable communities.
Elsevier,
Journeys of Embodiment at the Intersection of Body and Culture, The Developmental Theory of Embodiment, 2017, Pages 1-42
This chapter advances goals 3 and 5 by examining the description of the Developmental Theory of Embodiment, including two personal examples.
Background Since 2002, Afghanistan has made much effort to achieve universal health coverage.
Elsevier,
Health Reform Policy to Practice, Oregon's Path to a Sustainable Health System: A Study in Innovation, 2017, Pages 313-332
Offers valuable lessons to develop new payment and delivery models for affordable care that aim to realign incentives and emphasize accountability for quality and efficiency.
This book chapter advances SDG 3, 6, and 12 by demonstrating the major water pollutants of incipient concern, their source, and fate.
This book chapter advances SDGs 3 and 10 by providing a summary of recent studies of the relation of poverty to chronic kidney disease and related outcomes.
This book chapter advances SDGs 3 and 10 by ensuring equitable access to medications, technologies and clinical care are central to service delivery for effective screening, prevention and kidney disease management.